Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 4;13(11):1962.
doi: 10.3390/diagnostics13111962.

Salivary Biomarkers of Anti-Epileptic Drugs: A Narrative Review

Affiliations
Review

Salivary Biomarkers of Anti-Epileptic Drugs: A Narrative Review

Ioana-Andreea Chiș et al. Diagnostics (Basel). .

Abstract

Saliva is a biofluid that reflects general health and that can be collected in order to evaluate and determine various pathologies and treatments. Biomarker analysis through saliva sampling is an emerging method of accurately screening and diagnosing diseases. Anti-epileptic drugs (AEDs) are prescribed generally in seizure treatment. The dose-response relationship of AEDs is influenced by numerous factors and varies from patient to patient, hence the need for the careful supervision of drug intake. The therapeutic drug monitoring (TDM) of AEDs was traditionally performed through repeated blood withdrawals. Saliva sampling in order to determine and monitor AEDs is a novel, fast, low-cost and non-invasive approach. This narrative review focuses on the characteristics of various AEDs and the possibility of determining active plasma concentrations from saliva samples. Additionally, this study aims to highlight the significant correlations between AED blood, urine and oral fluid levels and the applicability of saliva TDM for AEDs. The study also focuses on emphasizing the applicability of saliva sampling for epileptic patients.

Keywords: anti-epileptic drugs; biomarkers; epilepsy; saliva; seizure; therapeutic drug monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Gug I., Tertis M., Ilea A., Chiș I.A., Băbțan A.M., Uriciuc W.A., Ionel A., Feurdean C.N., Boșca A.B., Cristea C. Salivary Biomarkers in Toxicology: An Update Narrative. In: Patel V.B., Preedy V.R., Rajendram R., editors. Biomarkers in Toxicology. Springer International Publishing; Cham, Switzerland: 2022. [(accessed on 13 January 2023)]. pp. 1–27. Biomarkers in Disease: Methods, Discoveries and Applications. Available online: https://link.springer.com/10.1007/978-3-030-87225-0_70-1. - DOI
    1. FDA-NIH Biomarker Working Group . BEST (Biomarkers, EndpointS, and other Tools) Resource. Food and Drug Administration (US); Silver Spring, MD, USA: 2016. [(accessed on 6 March 2023)]. Available online: http://www.ncbi.nlm.nih.gov/books/NBK326791/ - PubMed
    1. Califf R.M. Biomarker definitions and their applications. Exp. Biol. Med. 2018;243:213–221. doi: 10.1177/1535370217750088. - DOI - PMC - PubMed
    1. Ilea A., Andrei V., Feurdean C., Băbțan A.M., Petrescu N., Câmpian R., Boșca A.B., Ciui B., Tertiș M., Săndulescu R., et al. Saliva, a Magic Biofluid Available for Multilevel Assessment and a Mirror of General Health—A Systematic Review. Biosensors. 2019;9:27. doi: 10.3390/bios9010027. - DOI - PMC - PubMed
    1. Schipper R.G., Silletti E., Vingerhoeds M.H. Saliva as research material: Biochemical, physicochemical and practical aspects. Arch. Oral. Biol. 2007;52:1114–1135. doi: 10.1016/j.archoralbio.2007.06.009. - DOI - PubMed

LinkOut - more resources